A carregar...

IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy – a retrospective case series focusing on dosing and tolerability

Abstract Background IncobotulinumtoxinA (Xeomin®) is a botulinum neurotoxin type A with established efficacy in the treatment of upper-limb spasticity in adults. This retrospective case series in a university hospital setting aimed to elucidate the safety and tolerability of incobotulinumtoxinA for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Angel León-Valenzuela, Juan Sánchez Palacios, Rogelio del Pino Algarrada
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-04-01
Colecção:BMC Neurology
Assuntos:
Acesso em linha:http://link.springer.com/article/10.1186/s12883-020-01702-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!